Cargando…
Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for ELANE Neutropenia
Heterozygous mutations in ELANE, the gene for neutrophil elastase, cause cyclic and congenital neutropenia through the programed cell death of neutrophil progenitors in the bone marrow. Granulocyte colony-stimulating factor is an effective therapy for these diseases, but alternative therapies are ne...
Autores principales: | Makaryan, Vahagn, Kelley, Merideth, Fletcher, Breanna, Archibald, Isabella, Poulsen, Tanoya, Dale, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431957/ https://www.ncbi.nlm.nih.gov/pubmed/36052149 http://dx.doi.org/10.33696/immunology.4.129 |
Ejemplares similares
-
Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropenia
por: Sabo, Peter, et al.
Publicado: (2022) -
P755: STUDIES OF THE SPECIFIC TCIRG1 MUTATIONS CAUSING CONGENITAL NEUTROPENIA
por: Makaryan, Vahagn, et al.
Publicado: (2023) -
Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation
por: van de Vosse, Esther, et al.
Publicado: (2010) -
CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients
por: Nasri, Masoud, et al.
Publicado: (2020) -
Neutrophil Elastase Defects in Congenital Neutropenia
por: Rydzynska, Zuzanna, et al.
Publicado: (2021)